Aberrant activation of signal transducer and activator of transcription-3 (STAT3) signaling in endometriosis

Human Reproduction

Volumn 30, Issue 5, 2015, Pages 1069-1078

  Kim, Byung Gak ^a   Yoo, Jung Yoon ^a   Kim, Tae Hoon ^a   Shin, Jung Ho ^b   Langenheim, John F ^c   Ferguson, Susan D ^a   Fazleabas, Asgerally T ^a,d   Young, Steven L ^e   Lessey, Bruce A ^c   Jeong, Jae Wook ^a,d  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b Korea University College of Medicine   (South Korea)

^c GREENVILLE HOSPITAL SYSTEM   (United States)

^d SPECTRUM HEALTH   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

endometriosis; HIF1A; IL6; STAT3

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; MESSENGER RNA; STAT3 PROTEIN; ESTRADIOL; HIF1A PROTEIN, HUMAN; STAT3 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BABOON; CONTROLLED STUDY; ENDOMETRIAL CANCER CELL LINE; ENDOMETRIOSIS; ENDOMETRIUM; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; NONHUMAN; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; ADOLESCENT; ADULT; ANIMAL; BIOPSY; BLOOD; CHEMISTRY; CROSS-SECTIONAL STUDY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PHOSPHORYLATION; TUMOR CELL LINE; YOUNG ADULT;

ANIMALIA; PAPIO; PRIMATES;

ADOLESCENT; ADULT; ANIMALS; BIOPSY; CELL LINE, TUMOR; CROSS-SECTIONAL STUDIES; ENDOMETRIOSIS; ENDOMETRIUM; ESTRADIOL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; MIDDLE AGED; PAPIO; PHOSPHORYLATION; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; YOUNG ADULT;

EID: 84929716718     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dev050     Document Type: Article

References (53)

1. Afshar Y, Hastings J, Roqueiro D, Jeong JW, Giudice LC, Fazleabas AT. Changes in eutopic endometrial gene expression during the progression of experimental endometriosis in the baboon, Papio anubis. Biol Reprod 2013;88:44.
2. Aznaurova YB, Zhumataev MB, Roberts TK, Aliper AM, Zhavoronkov AA. Molecular aspects of development and regulation of endometriosis. Reprod Biol Endocrinol 2014;12:50.
3. Boutten A, Dehoux M, Edelman P, Seta N, Menard A, Madelenat P, Durand G. IL6 and acute phase plasma proteins in peritoneal fluid of women with endometriosis. Clin Chim Acta 1992;210:187-195.
4. Braundmeier AG, Fazleabas AT. The non-human primate model of endometriosis: research and implications for fecundity. Mol Hum Reprod 2009;15:577-586.
5. Bulun SE. Endometriosis. N Engl J Med 2009;360:268-279.
6. Bulun SE, Zeitoun KM, Kilic G. Expression of dioxin-related transactivating factors and target genes in human eutopic endometrial and endometriotic tissues. Am J Obstet Gynecol 2000;182:767-775.
7. Buyalos RP, Funari VA, Azziz R, Watson JM, Martinez-Maza O. Elevated interleukin-6 levels in peritoneal fluid of patients with pelvic pathology. Fertil Steril 1992;58:302-306.
8. Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, Snyder EY, Sulman EP, Anne SL, Doetsch F, Colman H et al. The transcriptional network for mesenchymal transformation of brain tumours. Nature 2010;463: 318-325.
9. Couto JP, Daly L, Almeida A, Knauf JA, Fagin JA, Sobrinho-Simoes M, Lima J, Maximo V, Soares P, Lyden D et al. STAT3 negatively regulates thyroid tumorigenesis. Proc Natl Acad Sci USA 2012;109:E2361-E2370.
10. Croxtall JD, Elder MG, White JO. Hormonal control of proliferation in the Ishikawa endometrial adenocarcinoma cell line. J Steroid Biochem 1990; 35:665-669.
11. Darnell Jr. JE. STATs and gene regulation. Science 1997;277:1630-1635.
12. D'Hooghe TM, Bambra CS, Suleman MA, Dunselman GA, Evers HL, Koninckx PR. Development of a model of retrograde menstruation in baboons (Papio anubis). Fertil Steril 1994;62:635-638.
13. D'Hooghe TM, Kyama CM, Chai D, Fassbender A, Vodolazkaia A, Bokor A, Mwenda JM. Nonhuman primate models for translational research in endometriosis. Reprod Sci 2009;16:152-161.
14. Fagard R, Metelev V, Souissi I, Baran-Marszak F. STAT3 inhibitors for cancer therapy: have all roads been explored?. JAKSTAT 2013;2:e22882.
15. FazleabasAT.Ababoon model for inducing endometriosis. Methods MolMed 2006;121:95-99.
16. Fazleabas AT, Brudney A, Gurates B, Chai D, Bulun S. A modified baboon model for endometriosis. Ann N Y Acad Sci 2002;955:308-317; discussion 340-342, 396-406.
17. Ferrajoli A, Faderl S, Van Q, Koch P, Harris D, Liu Z, Hazan-Halevy I, Wang Y, Kantarjian HM, Priebe W et al. WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells. Cancer Res 2007;67:11291-11299.
18. Fletcher S, Singh J, Zhang X, Yue P, Page BD, Sharmeen S, Shahani VM, Zhao W, Schimmer AD, Turkson J et al. Disruption of transcriptionally active Stat3 dimers with non-phosphorylated, salicylic acid-based small molecules: potent in vitro and tumor cell activities. Chembiochem 2009; 10:1959-1964.
19. Gashaw I, Stiller S, Boing C, Kimmig R, Winterhager E. Premenstrual regulation of the pro-Angiogenic factor CYR61 in human endometrium. Endocrinology 2008;149:2261-2269.
20. Gilabert-Estelles J, Ramon LA, Espana F, Gilabert J, Vila V, Reganon E, Castello R, Chirivella M, Estelles A. Expression of angiogenic factors in endometriosis: relationship to fibrinolytic and metalloproteinase systems. Hum Reprod 2007;22:2120-2127.
21. He G, Karin M. NF-kappaB and STAT3-key players in liver inflammation and cancer. Cell Res 2011;21:159-168.
22. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F. Principles of interleukin (IL)-6-Type cytokine signalling and its regulation. Biochem J 2003;374:1-20.
23. Henze AT, Acker T. Feedback regulators of hypoxia-inducible factors and their role in cancer biology. Cell Cycle 2010;9:2749-2763.
24. Ishibashi H, Suzuki T, Suzuki S, MoriyaT, KanekoC, Takizawa T, Sunamori M, Handa M, Kondo T, Sasano H. Sex steroid hormone receptors in human thymoma. J Clin Endocrinol Metab 2003;88:2309-2317.
25. Juhasz-Boss I, Fischer C, Lattrich C, Skrzypczak M, Malik E, Ortmann O, Treeck O. Endometrial expression of estrogen receptor beta and its splice variants in patients with and without endometriosis. Arch Gynecol Obstet 2011;284:885-891.
26. Kamimura D, Ishihara K, Hirano T. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol 2003;149:1-38.
27. Karalok HM, Karalok E, Saglam O, Torun A, Guzeloglu-Kayisli O, Lalioti MD, Kristansson H, Duke CM, Choe G, Flannery C. et al. mRNA-binding protein TIA-1 reduces cytokine expression in human endometrial stromal cells and is down-regulated in ectopic endometrium. J Clin Endocrinol Metab 2014; jc20133488.
28. Kroon P, Berry PA, Stower MJ, Rodrigues G, Mann VM, Simms M, Bhasin D, Chettiar S, Li C, Li PKet al. JAK-STATblockade inhibits tumor initiation and clonogenic recovery of prostate cancer stem-like cells. Cancer Res 2013; 73:5288-5298.
29. Lee JH, Kim TH, Oh SJ, Yoo JY, Akira S, Ku BJ, Lydon JP, Jeong JW. Signal transducer and activator of transcription-3 (Stat3) plays a critical role in implantation via progesterone receptor in uterus. FASEB J 2013; 27:2553-2563.
30. Li MQ, Shao J, Meng YH, Mei J, Wang Y, Li H, Zhang L, Chang KK, Wang XQ, Zhu XY et al. NME1 suppression promotes growth, adhesion and implantation of endometrial stromal cells via Akt and MAPK/Erk1/2 signal pathways in the endometriotic milieu. Hum Reprod 2013; 28:2822-2831.
31. Lu L, Li C, Li D, Wang Y, Zhou C, ShaoW, Peng J, You Y, Zhang X, Shen X. Cryptotanshinone inhibits human glioma cell proliferation by suppressing STAT3 signaling. Mol Cell Biochem 2013;381:273-282.
32. Lu Z, Zhang W, Jiang S, Zou J, Li Y. Effect of oxygen tensions on the proliferation and angiogenesis of endometriosis heterograft in severe combined immunodeficiency mice. Fertil Steril 2014;101:568-576.
33. May KE, Villar J, Kirtley S, Kennedy SH, Becker CM. Endometrial alterations in endometriosis: a systematic review of putative biomarkers. Hum Reprod Update 2011;17:637-653.
34. Maybin JA, Hirani N, Brown P, Jabbour HN, Critchley HO. The regulation of vascular endothelial growth factor by hypoxia and prostaglandin F(2)alpha during human endometrial repair. J Clin Endocrinol Metab 2011; 96:2475-2483.
35. McLaren J. Vascular endothelial growth factor and endometriotic angiogenesis. Hum Reprod Update 2000;6:45-55.
36. Meola J, Hidalgo Gdos S, Silva JC, Silva LE, Paz CC, Ferriani RA. Caldesmon: new insights for diagnosing endometriosis. Biol Reprod 2013;88:122.
37. Nakamura H, Kimura T, Koyama S, Ogita K, Tsutsui T, Shimoya K, Taniguchi T, Koyama M, Kaneda Y, Murata Y. Mouse model of human infertility: transient and local inhibition of endometrial STAT-3 activation results in implantation failure. FEBS Lett 2006;580:2717-2722.
38. O'Donnell JL, Joyce MR, Shannon AM, Harmey J, Geraghty J, Bouchier-Hayes D. Oncological implications of hypoxia inducible factor-1alpha (HIF-1alpha) expression. Cancer Treat Rev 2006;32:407-416.
39. Oh HK, Choi YS, Yang YI, Kim JH, Leung PC, Choi JH. Leptin receptor is induced in endometriosis and leptin stimulates the growth of endometriotic epithelial cells through the JAK2/STAT3 and ERK pathways. Mol Hum Reprod 2013;19:160-168.
40. Pellicer A, Albert C, Mercader A, Bonilla-Musoles F, Remohi J, Simon C. The follicular and endocrine environment in women with endometriosis: local and systemic cytokine production. Fertil Steril 1998;70:425-431.
41. Semenza GL. HIF-1 and human disease: one highly involved factor. Genes Dev 2000;14:1983-1991.
42. Semenza GL. Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit Rev Biochem Mol Biol 2000;35:71-103.
43. Spinella F, Rosano L, Di Castro V, Decandia S, Nicotra MR, Natali PG, Bagnato A. Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1alpha in human melanoma cells. Cancer Res 2007;67:1725-1734.
44. Takeda K, Noguchi K, Shi W, Tanaka T, Matsumoto M, Yoshida N, Kishimoto T, Akira S. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci USA 1997;94:3801-3804.
45. Taylor RN, Lebovic DI, Mueller MD. Angiogenic factors in endometriosis. Ann N Y Acad Sci 2002;955:89-100; discussion 118, 396-406.
46. Tsudo T, Harada T, Iwabe T, Tanikawa M, Nagano Y, Ito M, Taniguchi F, Terakawa N. Altered gene expression and secretion of interleukin-6 in stromal cells derived from endometriotic tissues. Fertil Steril 2000; 73:205-211.
47. Wang Y, van Boxel-DezaireAH, Cheon H, Yang J, StarkGR. STAT3 activation in response to IL-6 is prolonged by the binding of IL-6 receptor to EGF receptor. Proc Natl Acad Sci USA 2013;110:16975-16980.
48. Wu MH, Chen KF, Lin SC, LguCW, Tsai SJ. Aberrant expression of leptin in human endometriotic stromal cells is induced by elevated levels of hypoxia inducible factor-1alpha. Am J Pathol 2007;170:590-598.
49. Wu MH, Lu CW, Chang FM, Tsai SJ. Estrogen receptor expression affected by hypoxia inducible factor-1alpha in stromal cells from patients with endometriosis. Taiwan J Obstet Gynecol 2012;51:50-54.
50. Xiong J, Zeng P, Cheng X, Miao S, Wu L, Zhou S, Wu P, Ye D. Lipoxin A4 blocks embryo implantation by controlling estrogen receptor alpha activity. Reproduction 2013;145:411-420.
51. Xu Q, Briggs J, Park S, Niu G, Kortylewski M, Zhang S, Gritsko T, Turkson J, Kay H, Semenza GL et al. Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene 2005;24:5552-5560.
52. Young SL, Lessey BA. Progesterone function in human endometrium: clinical perspectives. Semin Reprod Med 2010;28:5-16.
53. Zhong Z, Wen Z, Darnell Jr. JE. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 1994;264:95-98.